Search for: "PFIZER" Results 1081 - 1100 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2020, 1:48 am by Sophie Corke
Finally, he saw the approach of the Italian Competition Agency and ultimately the Italian Supreme Court in Pfizer as very difficult to understand from an IP lawyer’s perspective. [read post]
9 Mar 2020, 4:00 pm by Sabrina I. Pacifici
Seated around an oval table in the Cabinet Room were health experts from the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health, as well as pharmaceutical executives from Pfizer, Johnson & Johnson, Sanofi, and others. [read post]
3 Mar 2020, 4:30 am by Tom Kosakowski
Shaw will be available at the conference and for a limited time following the conference.Shaw is a ;former IOA Board Member and recently retired from Pfizer, where she served as an Ombuds the last six years as an Ombuds. [read post]
3 Mar 2020, 4:00 am by Alan Macek
Bell Helicopter Textron Canada Limitée, 2012 FC 113 citing Pfizer Canada Inc v Apotex Inc, 2007 FC 971, the Court said it is entitled to look at all the patents and other publications that a skilled technician would discover in a ‘reasonable and diligent search’ to determine whether the resulting ‘mosaic’ leads directly to the invention. [read post]
27 Feb 2020, 9:21 am by Sabrina I. Pacifici
A handful of others, including Pfizer and Morgan Stanley, have said they mandate it for U.S. employees or have an opt-out policy. [read post]
Featured Discussion Topics    The capital raising landscape and lessons learned    Spotlight on gene and cell therapy as an innovative and evolving technology area    Capitalizing on the commercial potential of direct-to-consumer genetic testing    Strategies for operationalizing a personalized medicine program at the point of care    The promise behind AI for… [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, Mr. [read post]
7 Feb 2020, 12:43 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
(based in Tennessee and a subsidiary of Sanofi); Pfizer (based in New York); and GlaxoSmithKline (based in Pennsylvania). [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
(based in Tennessee and a subsidiary of Sanofi); Pfizer (based in New York); and GlaxoSmithKline (based in Pennsylvania). [read post]
24 Jan 2020, 10:24 am by luiza
Illinois Average Wholesale Price (AWP) Litigation – In October 2019, the State of Illinois continued its string of successes against pharmaceutical companies for inflated pricing of prescription drugs paid for by the Illinois Medicaid program, reaching a $242 million settlement with more than a dozen drug companies, including Abbott Labs, Aventis, Forest Labs, GSK, Johnson & Johnson, Novartis, Pfizer, and others, for allegedly inflating the “average wholesale price”… [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
23 Jan 2020, 4:00 am by Alan Macek
Pfizer Canada Inc., 2018 FC 443, reversed 2018 FC 956 – The Prothonotary denied a motion on consent for issuance of a protective order on a similar basis as in Live Face on Web. [read post]
14 Jan 2020, 11:14 am by Rebecca Tushnet
First, internal Pfizer emails and an email response to a drug distributor who inquired if Hospira was marketing the generic version of Adrenalin were not “commercial advertising or promotion. [read post]
13 Jan 2020, 12:04 pm by Jim Walker
” The newspaper pointed out that other CR award winners included “the Gap and Nike (famous for using sweatshop workers), tobacco giant Altria (which owns Marlboro cigarettes), big banks including CitiGroup and Goldman Sachs, pharmaceutical giants such as Merck, Pfizer, and Johnson & Johnson, and even carbon-polluting power and oil companies, including XCEL Energy and ConocoPhillips. [read post]
13 Jan 2020, 12:04 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
10 Jan 2020, 9:32 am by Mike Delikat
Pfizer Pharmaceuticals, LLC, 730 F.3d 49 (1st Cir. 2013) (holding that district court erred in not applying the “reasonable certainty” test to a discretionary promotion). [read post]